NASDAQ: NVCNTSX: NVC VANCOUVER, Aug. 11, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that CEO Alexei Marko is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference on Wednesday, August 12th at 9:30 am ET in...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, Aug. 6, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the quarter ended June 30, 2015. "With steady activity in our tissue business, Reducer's European launch going well, and with additional successful Tiara implantations,...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, June 18, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) a specialty medical device company today announced that CFO Chris Clark is scheduled to present at the JMP Securities Life Sciences Conference in New York City on...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, June 16, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 16, 2015 in Vancouver, B.C....
Read More-- Raised aggregate gross proceeds of approximately US$74,883,850 ---- The New England Journal of Medicine publishes positive results from clinical study of Reducer ---- Company launches Reducer in select European countries -- NASDAQ: NVCNTSX: NVC VANCOUVER, May 12, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company")...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, May 4, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that CFO Chris Clark is scheduled to present at the Deutsche Bank 40th Annual Health Care Conference on Wednesday, May 6, 2015, at 12:50 pm...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, March 30, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the fourth quarter and full year ended December 31, 2014. All results are reported in Canadian dollars unless otherwise stated. 2014 Highlights First-in-human implantation...
Read MoreNASDAQ: NVCNTSX: NVC VANCOUVER, March 19, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced the Neovasc Reducer™ has been introduced to select centers in Italy and will shortly be available for routine use at additional sites in Germany, the...
Read More